PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 30942960 ↗2019Reported benefit

Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury.

MouseSpinal cord injuryCompressionICR (CD-1)Malen = 35 mice randomised into four groups; 5 spinal cords per gro…Intravenous (tail vein)1 x 10^6 cells per animal by intravenous injection; moringi…After induction of spinal cord damage

Model: Extradural compression of the spinal cord at T6-T7 with an aneurysm clip (closing force 24 g) applied for 1 min after T5-T8 laminectomy

Moringin-pretreated GMSCs produced earlier and greater locomotor recovery than GMSCs alone, with significant BMS improvement from day 4 post-injury (day 8 for GMSCs alone) and significantly higher scores than GMSCs alone from day 9. Spinal cord morphology was restored, COX-2, IL-1beta, IL-6 and GFA…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.